Merck (NYSE:MRK) stock in focus as the company partners with Jiangsu Hengrui in a $2B deal for heart disease therapy HRS-5346 ...
NANJING, March 26 (Xinhua) -- A microgrid project, the largest of its kind in east China's Jiangsu Province, began operations on Wednesday as the country strengthens its efforts to promote the use of ...
El conglomerado danés de tecnología e ingeniería Danfoss Group también ha experimentado un fuerte impulso en los sectores ...
Japanese and Chinese people have gathered under blooming cherry trees at a park in the Chinese city of Wuxi to celebrate ...
Apple will continue to invest in China "in a big way", as the country is a central part of the US tech company's critical ...
Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, ...
As the clock ticks down to the highly anticipated showdown between the China national football team and Australia, excitement is palpable among fans. This eighth round of the 2026 FIFA World Cup Asia ...
BEIJING -- Foreign direct investment (FDI) in the Chinese mainland in actual use reached 171.21 billion yuan (about $23.87 ...
Children try to stand eggs at a kindergarten in Nanjing, east China's Jiangsu Province, March 20, 2025. Spring Equinox, or ...
2 天
Stocktwits on MSNMerck Enters $2B License Agreement With China-Based Hengrui Pharma For Heart Disease Drug ...Merck & Co., Inc. (MRK) said on Tuesday that it hasentered into an exclusive license agreement with China-based Jiangsu ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果